Management of Post-Traumatic Nightmares: a Review of Pharmacologic and Nonpharmacologic Treatments Since 2013

AbstractPurpose of ReviewPost-traumatic nightmares (PTN) are a common and enduring problem for individuals with post-traumatic stress disorder (PTSD) and other clinical presentations. PTN cause significant distress, are associated with large costs, and are an independent risk factor for suicide. Pharmacological and non-pharmacological treatment options for PTN exist. A previous review in this journal demonstrated that Prazosin, an alpha blocker, was a preferred pharmacological treatment for PTN and imagery rescripting therapy (IRT) was a preferred non-pharmacological treatment. Since that time, new and important research findings create the need for an updated review.Recent FindingsBased on the results of a recent study in the New England Journal of Medicine, Prazosin has been downgraded by both the American Academy of Sleep Medicine (AASM) and the Veterans Health Administration/Department of Defense (VA/DoD) for PTN. In Canada, Nabilone, a synthetic cannabinoid, appears to be promising. Few recent studies have been published on non-pharmacological interventions for PTN; however, recent data is available with regard to using IRT on an inpatient setting, with German combat veterans, and through the use of virtual technology. Recent evidence supports the use of exposure, relaxation, and rescripting therapy (ERRT) with children and individuals with comorbid bipolar disorder and PTN.SummaryPrazosin is no longer considered a first-line pharmacological intervention for PTN by AASM ...
Source: Current Psychiatry Reports - Category: Psychiatry Source Type: research

Related Links:

CONCLUSION Higher brain cortisol–producing 11β-HSD1 in the PTSD group may represent a resilience-promoting neuroadaptation resulting in lower PTSD symptoms. Along with preliminary associations between 11β-HSD1 and TSPO, corroborating previous evidence of immune suppression in PTSD, these findings collectively challenge previous hypotheses of the deleterious effects of both excessive brain glucocorticoid and brain immune signaling in PTSD.FUNDING Brain and Behavior Research Foundation Independent Investigator Grant, National Institute of Mental Health grants F30MH116607 and R01MH110674, the Veterans Affairs ...
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Source Type: research
AbstractThe anterior pituitary gland secretes several endocrine hormones, essential for growth, reproduction and other basic physiological functions. Abnormal development or function of the pituitary gland leads to isolated or combined pituitary hormone deficiency (CPHD). At least 30 genes have been associated with human CPHD, including many transcription factors, such asPOU1F1. CPHD occurs spontaneously also in mice and dogs. Two affected breeds have been reported in dogs: German Shepherds with a splice defect in theLHX3 gene and Karelian Bear Dogs (KBD) with an unknown genetic cause. We obtained samples from five KBDs pr...
Source: Human Genetics - Category: Genetics & Stem Cells Source Type: research
The CDC added depression and schizophrenia to its underlying conditions list, further proving that mental health is health.
Source: Healthy Living - The Huffington Post - Category: Consumer Health News Source Type: news
Findings presented at ECTRIMS 2021 suggest the OTC supplement improves multiple sleep measuresMedscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
There's a great divide in Dryden, Ontario's smallest city: People needing immediate help for addictions and homelessness are being told it'll take time to put evidence-based solutions like safe consumption sites in place. But for individuals like Shauna Pinkerton, time isn't on their side.
Source: CBC | Health - Category: Consumer Health News Tags: News/Canada/Thunder Bay Source Type: news
Conditions:   Suicide Attempts;   Suicidal Ideation;   Suicide and Self-harm;   Suicide Threat Interventions:   Behavioral: Safety Planning Intervention+ (SPI+);   Behavioral: Collaborative Assessment and Management of Suicidality (CAMS) Sponsors:   Seattle Children's Hospital;   Nationwide Children's Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Chronic Low-back Pain Interventions:   Other: Conventional Therapy Program;   Other: Basic Body Awareness Therapy Group Program Sponsor:   Hacettepe University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Respiratory Disease Intervention:   Other: Chest ultrasound Sponsor:   Mount Sinai Hospital, Canada Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Stanford psychiatrist's company has identified 11 drugs, including three already in mid-stage clinical trials, to more precisely target people with depression and PTSD.
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
An inpatient psychiatric diagnosis over an individual's lifetime is significantly associated with poor sleep quality, results from the largest study of its kind show.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Psychiatry News Source Type: news
More News: Academies | Bipolar | Canada Health | Children | Cognitive Behavior Therapy | Depression | Germany Health | Insomnia | Mania | Nightmares | Post Traumatic Stress Disorder | Psychiatry | Sleep Disorders | Sleep Medicine | Study | Suicide